Robert I Blum Cytokinetics Inc (CYTK) insider trading activity

CYTK Quotes by TradingView

Robert I Blum is President & CEO of CYTOKINETICS INC. Currently has a direct ownership of 399,604 shares of CYTK, which is worth approximately $26.5 Million. The most recent transaction as insider was on Oct 02, 2020, when has been sold 5,000 shares (Common Stock) at a price of $22.53 per share, resulting in proceeds of $112,650. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 400K
10.05% 3M change
0.93% 12M change
Total Value Held $26.5 Million

Robert I Blum Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 02 2020
SELL
Open market or private sale
$112,650 $22.53 p/Share
5,000 Reduced 1.61%
304,868 Common Stock
Oct 02 2020
BUY
Exercise of conversion of derivative security
$30,000 $6.0 p/Share
5,000 Added 1.59%
309,868 Common Stock

Also insider at

GMDA
Gamida Cell Ltd. Healthcare
Director
RIB

Robert I Blum

President & CEO
South San Francisco, CA

Track Institutional and Insider Activities on CYTK

Follow CYTOKINETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

News

Receive news related to CYTOKINETICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYTK